Upper renal tract deterioration after cyclophosphamide-induced cystitis: the case for monitoring after cyclophosphamide therapy.
Sweeney
J P
JP
Department of Urology, Meath Hospital, Dublin, Ireland.
Fan
C W
CW
Keogh
J A
JA
Thornhill
J A
JA
D000328:Adult; D003520:Cyclophosphamide / Q000009:adverse effects*; D003556:Cystitis / Q000139:chemically induced*; D005260:Female; D005355:Fibrosis / Q000139:chemically induced; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D006869:Hydronephrosis / Q000139:chemically induced; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D014515:Ureteral Diseases / Q000139:chemically induced*; D014718:Vesico-Ureteral Reflux / Q000209:etiology
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide